This is the web version of STAT’s special newsletter from the annual meeting of the American Society of Oncology. For more ...

ASCO 2025 delivered pivotal updates. In this article, we discuss 8 of the more interesting abstracts from an investment ...

Treating patients with lung cancer always calls for a focus on informed and shared decision-making, according to expert ...

This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...

The first half of this year has been riddled with market volatility and geopolitical tension. But 2025’s American Society of ...

An ASCO session on quality services shows how patient and caregiver engagement is crucial to gain better outcomes and cost savings from symptom monitoring efforts. Vincent Picozzi, MD, medical ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...

After Bicara reported a 12-month OS of 61% for its HPV-negative population last week, biotech Merus shared that its ...

Dr Mariana Chavez MacGregor reports on advances from ASCO 2025, emphasizing treatment de-escalation and emerging tools like ctDNA for personalized care.

Dr. Joshua K. Sabari and Dr. Prantesh Jain delve into key lung cancer outcomes from the 2025 ASCO Meeting that patients should be aware of.

Harbinger Health has reported clinical data at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, ...

For patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast ...